Scientists from the University of Liverpool and their global collaborators have highlighted the most effective treatments for ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, announced the appointment ...

Pregnancy increases the risk of mental illness among women with multiple sclerosis (MS).Pregnant MS patients have a ...

Dr. Anelyssa D'Abreu, an associate professor of neurology in UVA's School of Medicine who specializes in geriatric neurology, talked with UVA Today about the newest study and shared ways people can ...

Published in the journal Neurology, the results showed that intensive blood pressure control for three and a half years ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion centers.

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...

Phase III Vivacity-MG3 trial shows that nipocalimab, an investigational FcRn blocker, significantly the improves symptoms of generalized myasthenia gravis with a manageable safety profile.

When faced with significant medical decisions, uncertainty can feel overwhelming. The stakes are high, and making the right ...

A new study led by Western researchers found frequent treatment with intranasal oxytocin—a hormone in the brain associated with empathy—offers promise for addressing a key symptom among patients with ...

The impact makes us cringe-the sound of two helmets making contact during a football game, a player down on the field.